Diagnosis and treatment of chronic cerebral ischemia. DIAMANT study results

Медицинский совет

V. A. Parfenov¹ 

[1] I.M.Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University);

关键词: chronic cerebral ischemia;    dyscirculatory encephalopathy;    vascular cognitive disorders;    stroke prevention;    divaza;    diamant study;   

DOI  :  10.21518/2079-701X-2018-9-8-12

来源: DOAJ

【 摘 要 】

The diagnosis of chronic cerebral ischemia (CHI) is based on the presence of vascular cognitive disorders (CD). Many patients diagnosed with CHI have other neurological or mental illnesses (primary headaches, vestibulopathies, anxiety and depressive disorders), which, unfortunately, are not diagnosed. Prevention of stroke, which is based on the correction of risk factors (smoking, alcohol abuse, low physical activity, and obesity), the treatment of hypertension, diabetes and other diseases is of major importance in the management of patients with CHI. Inhibitors of central acetyl cholinesterase and akatinol memantine showed efficacy in the management of significant vascular CD. The article discusses the issues of use of Divaza for the management of CHI, provides the results of DIAMANT multicentre observational study.

【 授权许可】

Unknown